Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Xs02 skin test for tuberculosis infection and auxiliary diagnosis
CTR20252082Phase 3Active
- Sponsor
- Simcere Xiangrui
- Start
- May 2025
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Xs02 in Tuberculosis (TB), sponsored by Simcere Xiangrui. Started May 2025; status: active.
02
Drugs
Xs02
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on CTR20252082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252082.